Bristol Myers' stock decline in response to weak guidance is a gift to investors

Feb 7, 2025 - 16:00

Bristol Myers' stock decline in response to weak guidance is a gift to investors

The heart of our investment thesis in the drugmaker remains intact.

Related Posts

Diamonds in the rough: Late-round gems of the 2025 draft

Diamonds in the rough: Late-round gems of the 2025 draft

Jun 23, 2025

Senators sign Zetterlund to three-year contract

Senators sign Zetterlund to three-year contract

Jun 20, 2025

Preds expect Josi for camp after POTS diagnosis

Preds expect Josi for camp after POTS diagnosis

Jun 18, 2025

Canes re-sign Robinson to 4-year, $6.8M deal

Canes re-sign Robinson to 4-year, $6.8M deal

Jun 20, 2025

Free agency and draft plans for Oilers, Panthers, every other team

Free agency and draft plans for Oilers, Panthers, every...

Jun 21, 2025

Bruins sign D Lohrei to 2-year, $6.4M extension

Bruins sign D Lohrei to 2-year, $6.4M extension

Jun 23, 2025